To date, more than 100 clinical trials with human pluripotent stem cell (hPSC)-derived products have been initiated worldwide and an increasing number of potential hPSC-derived clinical products have ...
Gadopiclenol only requires half of the gadolinium dose of conventional nonspecific GBCAs. Elucirem â„¢ (gadopiclenol) and Vueway â„¢ (gadopiclenol) are now available for use with magnetic resonance ...